» Authors » Ashley M Nelson

Ashley M Nelson

Explore the profile of Ashley M Nelson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 52
Citations 450
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Amonoo H, Bodd M, Reynolds M, Nelson A, Newcomb R, Johnson P, et al.
Blood Adv . 2021 Nov; 6(7):2435-2442. PMID: 34768282
Patients diagnosed with acute myeloid leukemia (AML) face sudden-onset life-threatening disease that requires intensive treatments. Although their early disease trajectory is characterized by significant, toxic side effects, limited data are...
22.
Johnson P, Markovitz N, Yi A, Newcomb R, Amonoo H, Nelson A, et al.
J Palliat Med . 2021 Nov; 25(5):728-733. PMID: 34724798
Aggressive non-Hodgkin lymphoma (NHL) commonly affects older adults and is often treated with intensive therapies. Receipt of intensive therapies and absence of a clear transition between the curative and palliative...
23.
Gonzalez B, Eisel S, Bowles K, Hoogland A, James B, Small B, et al.
J Natl Cancer Inst . 2021 Sep; 114(6):808-818. PMID: 34508604
Background: Trials of immune checkpoint inhibitors (ICIs) have published patient-reported quality of life (QOL), but the size and heterogeneity of this literature can make patient education difficult. This meta-analysis aimed...
24.
Nelson A, Amonoo H, Kavanaugh A, Webb J, Jackson V, Rice J, et al.
Cancer . 2021 Aug; 127(24):4702-4710. PMID: 34460937
Background: It has been shown previously that integrated palliative care for patients with acute myeloid leukemia (AML) during intensive chemotherapy leads to improvements in quality of life (QOL) and mood....
25.
Nowak A, Gross A, Sherman E, Rodriguez A, Ventuleth M, Nelson A, et al.
ACS Appl Mater Interfaces . 2021 Aug; 13(35):42005-42013. PMID: 34427422
A passive icephobic coating (τ < 20 kPa) is an enabling technology to many industries, including aerospace and energy and power generation, with recent efforts in materials research identifying strategies...
26.
Oswald L, Hyland K, Eisel S, Hoogland A, Knoop H, Nelson A, et al.
Support Care Cancer . 2021 Jul; 30(1):87-94. PMID: 34231041
Purpose: Tyrosine kinase inhibitors (TKIs) substantially improve survival for patients with chronic myeloid leukemia (CML), but fatigue associated with TKIs can negatively impact patients' quality of life and adherence. This...
27.
Hyland K, Nelson A, Eisel S, Hoogland A, Ibarz-Pinilla J, Sweet K, et al.
Ann Behav Med . 2021 May; 56(2):137-145. PMID: 33991085
Background: Cognitive behavioral therapy for targeted-therapy related fatigue (CBT-TTF) has demonstrated preliminary efficacy in reducing fatigue in patients treated with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML). Purpose:...
28.
Nelson A, Johnson P, Kavanaugh A, Jackson V, Jagielo A, Fenech A, et al.
Bone Marrow Transplant . 2021 Apr; 56(8):1971-1977. PMID: 33824441
An inpatient palliative care intervention during HCT led to improvement in patient QOL and mood. We sought to describe components of the intervention, investigate differences in supportive care practices by...
29.
Waldman L, Nelson A, Jacobs J, Gray T, Clay M, Jagielo A, et al.
Transplant Cell Ther . 2021 Apr; 27(6):517.e1-517.e5. PMID: 33812804
Family and friends caring for hematopoietic stem cell transplantation (HCT) recipients experience substantial disruptions in daily life as they prepare for transplant. These disruptions may increase their psychological distress, yet...
30.
Nelson A, Hyland K, Small B, Kennedy B, Mishra A, Hoogland A, et al.
Ann Behav Med . 2021 Jan; 55(9):870-878. PMID: 33410478
Background: Fatigue is a prominent quality of life concern among recipients of hematopoietic cell transplantation (HCT). Purpose: The present study investigated whether objectively measured sleep efficiency and sedentary behavior are...